Advent France Biotechnology has appointed Anne Horgan as partner and Arnaud Foussat as operating partner.
Catch up on essential news and features from this past week with our round-up of industry analysis
Consortium of backers invests in the Dutch clinical-stage immuno-oncology company
Fund will target investments with positive social and environmental impact globally
Vehicle will invest in medium-sized Iberian companies with an enterprise value between €100-500m